Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
14/04/2014 | 16:47 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CADX | (MM) |
01/04/2014 | 23:12 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CADX | (MM) |
24/03/2014 | 16:29 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CADX | (MM) |
22/03/2014 | 00:43 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CADX | (MM) |
19/03/2014 | 21:17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CADX | (MM) |
19/03/2014 | 21:11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CADX | (MM) |
19/03/2014 | 21:07 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CADX | (MM) |
19/03/2014 | 14:45 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CADX | (MM) |
19/03/2014 | 14:12 | Business Wire | Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc. | NASDAQ:CADX | (MM) |
19/03/2014 | 11:42 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CADX | (MM) |
19/03/2014 | 11:23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CADX | (MM) |
13/03/2014 | 23:00 | Zacks | FDA Approves Mallinckrodt's Xartemis XR - Analyst Blog | NASDAQ:CADX | (MM) |
13/03/2014 | 21:11 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:CADX | (MM) |
10/03/2014 | 20:16 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CADX | (MM) |
06/03/2014 | 17:50 | PR Newswire (US) | Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare | NASDAQ:CADX | (MM) |
28/02/2014 | 22:17 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:CADX | (MM) |
28/02/2014 | 22:00 | PR Newswire (US) | Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results | NASDAQ:CADX | (MM) |
19/02/2014 | 21:48 | PR Newswire (US) | Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision,... | NASDAQ:CADX | (MM) |
19/02/2014 | 17:35 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:CADX | (MM) |
19/02/2014 | 12:02 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:CADX | (MM) |
17/02/2014 | 19:54 | Business Wire | SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connecti... | NASDAQ:CADX | (MM) |
14/02/2014 | 21:50 | PR Newswire (US) | CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout | NASDAQ:CADX | (MM) |
14/02/2014 | 19:06 | Business Wire | SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. | NASDAQ:CADX | (MM) |
14/02/2014 | 17:30 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:CADX | (MM) |
14/02/2014 | 15:21 | Edgar (US Regulatory) | Schedule 13g | NASDAQ:CADX | (MM) |
13/02/2014 | 23:33 | Business Wire | INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. & Its Board of Directors in Con... | NASDAQ:CADX | (MM) |
13/02/2014 | 21:24 | Business Wire | CADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX) in Relation to the Propose... | NASDAQ:CADX | (MM) |
12/02/2014 | 22:07 | PR Newswire (US) | SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. - CADX | NASDAQ:CADX | (MM) |
12/02/2014 | 17:26 | Business Wire | Cadence Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Sale to Mallinc... | NASDAQ:CADX | (MM) |
12/02/2014 | 16:31 | PR Newswire (US) | Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc. | NASDAQ:CADX | (MM) |